The efficacy of the novel fluoroquinolone finafloxacin was evaluated as a potential therapeutic in vitro and in vivo. following an intranasal infection of Francisella tularensis strain SchuS4 in BALB/c mice. We demonstrated that short treatment courses of finafloxacin provide high levels of protection. with a single dose resulting in a significant increase in time to death when compar... https://www.roneverhart.com/Field-Slacks-Mens-p10549/